tetano
Editor, Senior Moderator
Eur Heart J Case Rep
. 2020 Sep 9;4(FI1):1-7.
doi: 10.1093/ehjcr/ytaa287. eCollection 2020 Oct.
Pericardial effusion in patients with COVID-19: case series
Fran?ois Sauer[SUP] 1 [/SUP], Charlotte Dagrenat[SUP] 1 [/SUP], Philippe Couppie[SUP] 1 [/SUP], Gaelle Jochum[SUP] 1 [/SUP], Pierre Leddet[SUP] 1 [/SUP]
Affiliations
Abstract
Background: SARS-coronavirus-2 [coronavirus disease 2019 (COVID-19)] infection is a public health issue affecting millions of people. It started in Wuhan in China in December 2019 spreading rapidly worldwide.
Case summary: Three patients aged 51-84 developed a pericarditis related to COVID-19, associated for two of them with a myocarditis. Case 1 was a COVID-19 cardiac tamponade without myocarditis, confirmed by a positive chest computed tomography (CT) scan. Case 2 showed a COVID-19 myopericarditis, confirmed by a positive chest CT scan and a SARS-coronavirus-2 positive swab. Case 3 was a cardiac tamponade due to COVID-19 pericarditis, with a positive polymerase chain reaction on pericardial fluid. They were all treated by colchicine and their condition improved rapidly.
Discussion: Presumably rare, we reported three cases of pericardial effusions (PEs) occurring in a single cardiology centre. There is a higher incidence of COVID-19-related cardiac diseases such as pericarditis that can manifest as a minimal PE to a cardiac tamponade, which should result in a higher awareness of cardiologists. A systematic measure of the high-sensitivity troponin kinetic in patients affected by COVID-19 could be interesting in order to screen for potential myocarditis. Any unexplained haemodynamic failure or increased cardiac biomarkers should make the medical team search for myopericarditis by a transthoracic echocardiography.
Keywords: COVID-19; Cardiac tamponade; Case series; Myopericarditis; Pericardial effusion.
. 2020 Sep 9;4(FI1):1-7.
doi: 10.1093/ehjcr/ytaa287. eCollection 2020 Oct.
Pericardial effusion in patients with COVID-19: case series
Fran?ois Sauer[SUP] 1 [/SUP], Charlotte Dagrenat[SUP] 1 [/SUP], Philippe Couppie[SUP] 1 [/SUP], Gaelle Jochum[SUP] 1 [/SUP], Pierre Leddet[SUP] 1 [/SUP]
Affiliations
- PMID: 33415315
- PMCID: PMC7499573
- DOI: 10.1093/ehjcr/ytaa287
Abstract
Background: SARS-coronavirus-2 [coronavirus disease 2019 (COVID-19)] infection is a public health issue affecting millions of people. It started in Wuhan in China in December 2019 spreading rapidly worldwide.
Case summary: Three patients aged 51-84 developed a pericarditis related to COVID-19, associated for two of them with a myocarditis. Case 1 was a COVID-19 cardiac tamponade without myocarditis, confirmed by a positive chest computed tomography (CT) scan. Case 2 showed a COVID-19 myopericarditis, confirmed by a positive chest CT scan and a SARS-coronavirus-2 positive swab. Case 3 was a cardiac tamponade due to COVID-19 pericarditis, with a positive polymerase chain reaction on pericardial fluid. They were all treated by colchicine and their condition improved rapidly.
Discussion: Presumably rare, we reported three cases of pericardial effusions (PEs) occurring in a single cardiology centre. There is a higher incidence of COVID-19-related cardiac diseases such as pericarditis that can manifest as a minimal PE to a cardiac tamponade, which should result in a higher awareness of cardiologists. A systematic measure of the high-sensitivity troponin kinetic in patients affected by COVID-19 could be interesting in order to screen for potential myocarditis. Any unexplained haemodynamic failure or increased cardiac biomarkers should make the medical team search for myopericarditis by a transthoracic echocardiography.
Keywords: COVID-19; Cardiac tamponade; Case series; Myopericarditis; Pericardial effusion.